CDIIQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 CDIIQ pulled ahead of the other in Year 1
Combined, CDIIQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDIIQ + PFE for your $10,000?
CD International Enterprises, Inc. sources and distributes industrial products in China and the Americas. It operates through two segments, Trading and Consulting. The Trading segment sources and distributes various industrial commodities, such as iron ore, copper concentrate, and other minerals; and cannabidiol-related products. The Consulting segment provides business and management consulting services to public and private American and Chinese companies that operate primarily in China and the Americas. It offers its consulting services in the areas of general business consulting, Chinese regulatory advice, translation services, formation of entities in the People's Republic of China, coordination of professional resources, mergers and acquisitions, strategic alliances and partnerships, advice on effective means of accessing U.S. capital markets, coordination of Sarbanes-Oxley compliance, and corporate asset evaluations. This segment also identifies potential areas of growth; manages and coordinates necessary government approvals and licenses; and provides marketing services, investor relations services, and coordination of the preparation of required SEC filings. The company was formerly known as China Direct Industries, Inc. and changed its name to CD International Enterprises, Inc. in February 2012. CD International Enterprises, Inc. was founded in 2005 and is headquartered in Plantation, Florida.
Full CDIIQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.